This study is active but not recruiting. It focuses on bipolarity and currently lists study information in the United States, Australia, and Canada.
This study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
The official record suggests in-person participation through a hospital, with sites including Collaborative Neuroscience Research LLC in Garden Grove, Synergy San Diego in Lemon Grove, and Collaborative Neuroscience Research LLC in Torrance. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually being able to understand the study and consent and matching the main diagnosis, while common reasons not to take part include active substance or alcohol problems that could affect the results. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.
This study may matter because it is evaluating ERG assessment (RSPA) in a structured research setting. For people exploring bipolarity research, clear information about the goal, status, contacts, and official source can support better questions before any decision.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Open source recordThis form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.
Taking part may give access to a new approach being evaluated.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in United States.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring medical device for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by diaMentis Inc.. Based on the sponsor name or official registry information, it appears to be another type of organization. You should verify the details in the official registry record.
This study may involve medical device, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.